Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Liabilities and Shareholders Equity (2016 - 2021)

Historic Liabilities and Shareholders Equity for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $27.9 million.

  • Phio Pharmaceuticals' Liabilities and Shareholders Equity rose 5320.47% to $27.9 million in Q3 2021 from the same period last year, while for Dec 2021 it was $93.5 million, marking a year-over-year increase of 3644.41%. This contributed to the annual value of $15.7 million for FY2020, which is 9578.31% up from last year.
  • Latest data reveals that Phio Pharmaceuticals reported Liabilities and Shareholders Equity of $27.9 million as of Q3 2021, which was up 5320.47% from $31.7 million recorded in Q2 2021.
  • In the past 5 years, Phio Pharmaceuticals' Liabilities and Shareholders Equity registered a high of $33.9 million during Q1 2021, and its lowest value of $3.1 million during Q1 2018.
  • For the 5-year period, Phio Pharmaceuticals' Liabilities and Shareholders Equity averaged around $13.8 million, with its median value being $12.1 million (2019).
  • In the last 5 years, Phio Pharmaceuticals' Liabilities and Shareholders Equity tumbled by 7060.5% in 2018 and then soared by 34265.37% in 2019.
  • Phio Pharmaceuticals' Liabilities and Shareholders Equity (Quarter) stood at $4.1 million in 2017, then soared by 273.89% to $15.3 million in 2018, then crashed by 47.53% to $8.0 million in 2019, then soared by 95.78% to $15.7 million in 2020, then surged by 77.54% to $27.9 million in 2021.
  • Its Liabilities and Shareholders Equity was $27.9 million in Q3 2021, compared to $31.7 million in Q2 2021 and $33.9 million in Q1 2021.